Skip to main content
Top
Published in: Critical Care 1/2019

Open Access 01-12-2019 | Stroke | Letter

Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial

Authors: N. Engrand, M. Mazighi, V. Dinkelacker

Published in: Critical Care | Issue 1/2019

Login to get access

Excerpt

Therapeutic hypothermia (TH) is currently evaluated in acute brain injury of diverse etiologies. In the clinical trial DEPTH-SOS, Neugebauer et al. [1] reported negative results for TH (33 ± 1 °C) in malignant acute ischemic stroke (AIS) in adjunction to decompressive hemicraniectomy. TH improved neither survival at day 14 or at 12 months, nor long-term functional outcome. Instead, severe adverse events (SAE) in the TH-group entailed premature trial discontinuation. We revisit the study design with regard to its clinical objectives. …
Literature
2.
go back to reference Vigué B, Ract C, Zlotine N, et al. Relationship between intracranial pressure, mild hypothermia and temperature-corrected PaCO2 in patients with traumatic brain injury. Intensive Care Med. 2000;26:722–8.CrossRef Vigué B, Ract C, Zlotine N, et al. Relationship between intracranial pressure, mild hypothermia and temperature-corrected PaCO2 in patients with traumatic brain injury. Intensive Care Med. 2000;26:722–8.CrossRef
Metadata
Title
Hypothermia after decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke: comment on the randomized clinical trial
Authors
N. Engrand
M. Mazighi
V. Dinkelacker
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2019
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-019-2452-3

Other articles of this Issue 1/2019

Critical Care 1/2019 Go to the issue